The immuno-behavioural covariation associated with the treatment response to bumetanide in young children with autism spectrum disorder.
Qingyang Li,
Lingli Zhang,
Haidi Shan,
Juehua Yu,
Yuan Dai,
Hua He,
Wei-Guang Li,
Christelle Langley,
Barbara Sahakian,
Yin Yao,
Qiang Luo,
Fei Li
Jun 07, 2022
Bumetanide, a drug being studied in autism spectrum disorder (ASD) may act to restore gamma-aminobutyric acid (GABA) function, which may be modulated by the immune system. However, the interaction between bumetanide and the...